Singh H, Shyamveer , Jori C, Mahajan S, Aalinkeel R, Kaliyappan K
Heliyon. 2024; 10(9):e30519.
PMID: 38742060
PMC: 11089352.
DOI: 10.1016/j.heliyon.2024.e30519.
Tang X, Zhou H, Yan H, Niimi M, Fan J
J Atheroscler Thromb. 2022; 29(7):1117-1124.
PMID: 35545534
PMC: 9252641.
DOI: 10.5551/jat.LE002.
Recio-Lopez P, Valladolid-Acebes I, Berggren P, Juntti-Berggren L
Int J Mol Sci. 2022; 23(1).
PMID: 35008488
PMC: 8744831.
DOI: 10.3390/ijms23010062.
Fan J, Wang Y, Chen Y
Front Genet. 2021; 12:614379.
PMID: 33603774
PMC: 7885269.
DOI: 10.3389/fgene.2021.614379.
Valladolid-Acebes I, Berggren P, Juntti-Berggren L
Int J Mol Sci. 2021; 22(2).
PMID: 33477763
PMC: 7832341.
DOI: 10.3390/ijms22020932.
Apolipoprotein C-III and cardiovascular diseases: when genetics meet molecular pathologies.
Dib I, Khalil A, Chouaib R, El-Makhour Y, Noureddine H
Mol Biol Rep. 2021; 48(1):875-886.
PMID: 33389539
PMC: 7778846.
DOI: 10.1007/s11033-020-06071-5.
The Roles of ApoC-III on the Metabolism of Triglyceride-Rich Lipoproteins in Humans.
Boren J, Packard C, Taskinen M
Front Endocrinol (Lausanne). 2020; 11:474.
PMID: 32849270
PMC: 7399058.
DOI: 10.3389/fendo.2020.00474.
Apolipoprotein CIII Deficiency Protects Against Atherosclerosis in Knockout Rabbits.
Yan H, Niimi M, Matsuhisa F, Zhou H, Kitajima S, Chen Y
Arterioscler Thromb Vasc Biol. 2020; 40(9):2095-2107.
PMID: 32757647
PMC: 7484272.
DOI: 10.1161/ATVBAHA.120.314368.
Life is complicated: so is apoCIII.
Reyes-Soffer G, Ginsberg H
J Lipid Res. 2019; 60(8):1347-1349.
PMID: 31239286
PMC: 6672043.
DOI: 10.1194/jlr.C119000214.
Effects of APOC3 Heterozygous Deficiency on Plasma Lipid and Lipoprotein Metabolism.
Reyes-Soffer G, Sztalryd C, Horenstein R, Holleran S, Matveyenko A, Thomas T
Arterioscler Thromb Vasc Biol. 2018; 39(1):63-72.
PMID: 30580564
PMC: 6309928.
DOI: 10.1161/ATVBAHA.118.311476.
Proteogenomic Review of the Changes in Primate apoC-I during Evolution.
Puppione D, Whitelegge J
Front Biol (Beijing). 2017; 8(5):533-548.
PMID: 28757862
PMC: 5528196.
DOI: 10.1007/s11515-013-1278-7.
Effects of a purified krill oil phospholipid rich in long-chain omega-3 fatty acids on cardiovascular disease risk factors in non-human primates with naturally occurring diabetes type-2 and dyslipidemia.
Hals P, Wang X, Xiao Y
Lipids Health Dis. 2017; 16(1):11.
PMID: 28095913
PMC: 5240272.
DOI: 10.1186/s12944-017-0411-z.
Why Is Apolipoprotein CIII Emerging as a Novel Therapeutic Target to Reduce the Burden of Cardiovascular Disease?.
Taskinen M, Boren J
Curr Atheroscler Rep. 2016; 18(10):59.
PMID: 27613744
PMC: 5018018.
DOI: 10.1007/s11883-016-0614-1.
The early years of lipoprotein research: from discovery to clinical application.
Siri-Tarino P, Krauss R
J Lipid Res. 2016; 57(10):1771-1777.
PMID: 27474223
PMC: 5036374.
DOI: 10.1194/jlr.R069575.
Effect of Leptin Administration on Circulating Apolipoprotein CIII levels in Patients With Lipodystrophy.
Kassai A, Muniyappa R, Levenson A, Walter M, Abel B, Ring M
J Clin Endocrinol Metab. 2016; 101(4):1790-7.
PMID: 26900642
PMC: 4880162.
DOI: 10.1210/jc.2015-3891.
Overexpression of apolipoprotein C-III decreases secretion of dietary triglyceride into lymph.
Wang F, Kohan A, Dong H, Yang Q, Xu M, Huesman S
Physiol Rep. 2014; 2(3):e00247.
PMID: 24760506
PMC: 4002232.
DOI: 10.1002/phy2.247.
Carboxyl terminus of apolipoprotein A-I (ApoA-I) is necessary for the transport of lipid-free ApoA-I but not prelipidated ApoA-I particles through aortic endothelial cells.
Ohnsorg P, Rohrer L, Perisa D, Kateifides A, Chroni A, Kardassis D
J Biol Chem. 2011; 286(10):7744-7754.
PMID: 21209084
PMC: 3048662.
DOI: 10.1074/jbc.M110.193524.
Detection of two distinct forms of apoC-I in great apes.
Puppione D, Ryan C, Bassilian S, Souda P, Xiao X, Ryder O
Comp Biochem Physiol Part D Genomics Proteomics. 2010; 5(1):73-9.
PMID: 20209111
PMC: 2830554.
DOI: 10.1016/j.cbd.2009.12.003.
Chylomicronemia due to apolipoprotein CIII overexpression in apolipoprotein E-null mice. Apolipoprotein CIII-induced hypertriglyceridemia is not mediated by effects on apolipoprotein E.
Ebara T, Ramakrishnan R, Steiner G, Shachter N
J Clin Invest. 1997; 99(11):2672-81.
PMID: 9169497
PMC: 508113.
DOI: 10.1172/JCI119456.
Combined hyperlipidemia in transgenic mice overexpressing human apolipoprotein Cl.
Shachter N, Ebara T, Ramakrishnan R, Steiner G, Breslow J, Ginsberg H
J Clin Invest. 1996; 98(3):846-55.
PMID: 8698877
PMC: 507495.
DOI: 10.1172/JCI118857.
